BRAWLEY OTIS W
SEC CIK 1213029 · EDGAR
BoughtSold
Most active insiders at INCY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hoppenot Herve | Dir | — | $19.77M |
| 2 | CAGNONI PABLO J | Pres, R, D | — | $14.10M |
| 3 | Stein Steven H | EVP, Chief Medical Off | — | $7.86M |
| 4 | Mayes Patrick A | EVP, CSO | — | $6.56M |
| 5 | Morrissey Michael James | EVP, Head of Tech. Ops | — | $5.68M |
| 6 | Clancy Paul J | Dir | — | $1.42M |
| 7 | Issa Mohamed Khairie | EVP, Head of US Oncology | — | $1.31M |
| 8 | Tray Thomas | Principal Accounting Off | — | $879.0K |
| 9 | Denton Sheila A. | EVP, GC | — | $465.2K |
| 10 | Heeson Lee | EVP, Head of Incyte Intl | — | $289.0K |
| 21 | BRAWLEY OTIS W | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-10 16:05 | 2026-06-08 | INCY | Incyte | BRAWLEY OTIS W | Dir | A - Grant | $0.00 | +1,642 | 12.9K | +15% | $0 |
| M | 2026-03-23 | 2026-03-19 | A | Agilent Technologies | BRAWLEY OTIS W | Dir | A - Grant | $111.75 | +3,046 | 13.9K | +28% | +$340.4K |
| D | 2025-06-12 | 2025-06-10 | INCY | Incyte | BRAWLEY OTIS W | Dir | A - Grant | $0.00 | +2,518 | 11.3K | +29% | $0 |
| 2025-04-02 | 2025-03-31 | LYEL | Lyell Immunopharma, Inc. | BRAWLEY OTIS W | Dir | P - Purchase | $0.56 | +35.6K | 35.6K | New | +$20.0K | |
| M | 2025-03-18 | 2025-03-14 | A | Agilent Technologies | BRAWLEY OTIS W | Dir | A - Grant | $121.18 | +2,631 | 10.7K | +32% | +$318.8K |
| D | 2024-06-14 | 2024-06-12 | INCY | Incyte | BRAWLEY OTIS W | Dir | A - Grant | $0.00 | +2,830 | 8,734 | +48% | $0 |
| M | 2024-03-19 | 2024-03-15 | A | Agilent Technologies | BRAWLEY OTIS W | Dir | A - Grant | $147.48 | +2,428 | 7,305 | +50% | +$358.1K |
| D | 2023-06-16 | 2023-06-14 | INCY | Incyte | BRAWLEY OTIS W | Dir | A - Grant | $0.00 | +2,505 | 5,904 | +74% | $0 |
| M | 2023-03-20 | 2023-03-16 | A | Agilent Technologies | BRAWLEY OTIS W | Dir | A - Grant | $136.82 | +2,399 | 4,844 | +98% | +$328.2K |
| D | 2022-06-17 | 2022-06-15 | INCY | Incyte | BRAWLEY OTIS W | Dir | A - Grant | $0.00 | +2,144 | 3,399 | +171% | $0 |
| M | 2022-03-21 | 2022-03-17 | A | Agilent Technologies | BRAWLEY OTIS W | Dir | A - Grant | $136.82 | +2,582 | 2,369 | New | +$353.3K |
| M | 2021-11-19 | 2021-11-18 | A | Agilent Technologies | BRAWLEY OTIS W | Dir | A - Grant | $162.16 | +583 | 583 | New | +$94.5K |
| D | 2021-09-29 | 2021-09-27 | INCY | Incyte | BRAWLEY OTIS W | Dir | A - Grant | $0.00 | +1,255 | 1,255 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations